• Mashup Score: 2

    Despite the tough market conditions for the industry over the past 2–3 years, the biotechnology sector is poised for big things moving forward. Exciting advances in precision genome editing, cell therapy, synthetic biology, organs-on-chips, next-gen sequencing and artificial intelligence all bode well for the development of new therapies and the health of patients and the industry. In The State…

    Tweet Tweets with this article
    • Our 2nd annual State of Biotech is only 1 week away! Secure your free spot now for the #biotech virtual event of the year! https://t.co/JAKKw1KRrJ https://t.co/ogoxWjTjpW